Radiofrequency Thermal Ablation of Hepatic Metastases of Adrenocortical Cancer – A Case Report and Review of the Literature

Abstract

Aim: Radiofrequency thermal ablation (RFA) has shown promise as a technique for treating solid tumors. This method has been suggested as an alternative to surgery in patients with adrenocortical carcinoma (ACC).

Materials and Methods: We reviewed the literature, and report the case of a patient with stage 4 ACC who received intraoperative and percutaneous RFA of two liver metastasis according to a standard ablation protocol.

Results: Post-interventional imaging in our patient demonstrated that after both interventions, a stellar-like structure of vital tumor tissue had remained within the coagulation necrosis. This was the starting point of a fast and progressive tumor recurrence. We suspect heat-sink effects of blood vessels in the highly vascularized metastasis to cause the tumor recurrence. In literature, there are only a few reports of RFA in ACC patients. In addition, there is no large randomized trial investigating the efficacy of RFA against surgery in those patients.

Conclusions: Presently, RFA in ACC should be restricted to patients in whom surgery is contraindicated. It is necessary that strongly vascularized ACC metastases deserve a modified ablation protocol due to perfusion related cooling effects and to increase the efficacy of RFA.

Key words

hepatic metastases - adrenocortical cancer - radiofrequency thermal ablation - heat sink effects - liver

References

• 1 Abiven G, Coste J, Groussin L. et al . Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.  J Clin Endocrinol Metab. 2006;  91 2650-2655
• 2 Abraham J, Fojo T, Wood BJ. Radiofrequency ablation of metastatic lesions in adrenocortical cancer.  Ann Intern Med. 2000;  133 312-313
• 3 Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update.  J Clin Endocrinol Metab. 2006;  91 2027-2037
• 4 Brown DB. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation.  J Vasc Interv Radiol. 2005;  16 597-613
• 5 Chok KS, Ng KC, Lam CM. et al . Selective portal vein clamping for radiofrequency ablation of hepatocellular carcinoma with portal vein invasion.  J Gastrointest Surg. 2005;  9 489-493
• 6 Curley SA, Izzo F, Delrio P. et al . Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.  Ann Surg. 1999;  230 1-8
• 7 Beare T de, Bessoud B, Dromain C. et al . Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion.  AJR Am J Roentgenol. 2002;  178 53-59
• 8 Beare T de, Palussiere J, Auperin A. et al . Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.  Radiology. 2006;  240 587-596
• 9 Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer.  Dis Colon Rectum. 2000;  43 656-661
• 10 Goetz MP, Callstrom MR, Charboneau JW. et al . Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.  J Clin Oncol. 2004;  22 300-306
• 11 Hori T, Nagata K, Hasuike S. et al . Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.  J Gastroenterol. 2003;  38 977-981
• 12 Komorizono Y, Oketani M, Sako K. et al . Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.  Cancer. 2003;  97 1253-1262
• 13 Koschker AC, Fassnacht M, Hahner S. et al . Adrenocortical carcinoma – improving patient care by establishing new structures.  Exp Clin Endocrinol Diabetes. 2006;  114 45-51
• 14 Lin SM, Lin CJ, Lin CC. et al . Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma<or=4 cm.  Gastroenterology. 2004;  127 1714-1723
• 15 Livraghi T, Goldberg SN, Lazzaroni S. et al . Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.  Radiology. 2000;  214 761-768
• 16 Livraghi T, Goldberg SN, Lazzaroni S. et al . Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection.  Radiology. 1999;  210 655-661
• 17 Lu DS, Raman SS, Limanond P. et al . Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.  J Vasc Interv Radiol. 2003;  14 1267-1274
• 18 Rhim H, Dodd GD, Chintapalli KN. et al . Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications.  Radiographics. 2004;  24 41-52
• 19 Schteingart DE, Doherty GM, Gauger PG. et al . Management of patients with adrenal cancer: recommendations of an international consensus conference.  Endocr Relat Cancer. 2005;  12 667-680
• 20 Solbiati L, Livraghi T, Goldberg SN. et al . Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.  Radiology. 2001;  221 159-166
• 21 Wajchenberg BL, Bergaria Pereira MA, Medonca BB. et al . Adrenocortical carcinoma: clinical and laboratory observations.  Cancer. 2000;  88 711-736
• 22 Wood BJ, Abraham J, Hvizda JL. et al . Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases.  Cancer. 2003;  97 554-560
• 23 Yamasaki T, Kurokawa F, Shirahashi H. et al . Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.  Cancer. 2002;  95 2353-2360

1 Both authors contributed equally to this work.

Correspondence